Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
British Journal of Cancer
|
December 21, 2021
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
Jason D Lickliter, Mark Voskoboynik, Linda Mileshkin, et al.
Cell Biochemistry and Biophysics
|
October 26, 2005
TFAR19 gene changes the biophysical properties of murine erythroleukemia cells
Li Gu, Yuhui Jiang, Ying Wang, et al.
Leukemia & Lymphoma
|
February 8, 2020
A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment
Ying C Ou, Richard A Preston, Thomas C Marbury, et al.
Clinical and Translational Science
|
March 8, 2020
No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy Subjects
Song Mu, Borje Darpo, Zhiyu Tang, et al.
Chinese Journal of Natural Medicines
|
February 18, 2026
Structural basis of the major TMPRSS2 promoter G-quadruplex and its complex with berberine
Zhiyu Tang, Yuting Bian, Shangran Li, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 4, 2022
Model-based population pharmacokinetic analysis of tislelizumab in patients with advanced tumors
Nageshwar Budha, Chi-Yuan Wu, Zhiyu Tang, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 12, 2025
Quantitative Systems Pharmacology Model to Predict Target Occupancy by Bruton Tyrosine Kinase Inhibitors in Patients With B-Cell Malignancies
Oleg Demin, Ying Ou, Galina Kolesova, et al.
Journal of Biomechanics
|
September 22, 2009
Ryanodine receptor 1 mediates Ca2+ transport and influences the biomechanical properties in RBCs
Xianwei Wang, Xi Chen, Zhiyu Tang, et al.
Angewandte Chemie (International Ed. in English)
|
March 7, 2026
Oxidative Damage Fine-Tunes G-Quadruplex Structures in Human Gene Promoters
Yu Wang, Yingying Wang, Rongshuang Cheng, et al.
Clinical and Translational Science
|
March 22, 2024
Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors
Tian Yu, Xiangyu Liu, Chi-Yuan Wu, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
British Journal of Cancer
|
December 21, 2021
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
Jason D Lickliter, Mark Voskoboynik, Linda Mileshkin, et al.
Cell Biochemistry and Biophysics
|
October 26, 2005
TFAR19 gene changes the biophysical properties of murine erythroleukemia cells
Li Gu, Yuhui Jiang, Ying Wang, et al.
Leukemia & Lymphoma
|
February 8, 2020
A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment
Ying C Ou, Richard A Preston, Thomas C Marbury, et al.
Clinical and Translational Science
|
March 8, 2020
No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy Subjects
Song Mu, Borje Darpo, Zhiyu Tang, et al.
Chinese Journal of Natural Medicines
|
February 18, 2026
Structural basis of the major TMPRSS2 promoter G-quadruplex and its complex with berberine
Zhiyu Tang, Yuting Bian, Shangran Li, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 4, 2022
Model-based population pharmacokinetic analysis of tislelizumab in patients with advanced tumors
Nageshwar Budha, Chi-Yuan Wu, Zhiyu Tang, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 12, 2025
Quantitative Systems Pharmacology Model to Predict Target Occupancy by Bruton Tyrosine Kinase Inhibitors in Patients With B-Cell Malignancies
Oleg Demin, Ying Ou, Galina Kolesova, et al.
Journal of Biomechanics
|
September 22, 2009
Ryanodine receptor 1 mediates Ca2+ transport and influences the biomechanical properties in RBCs
Xianwei Wang, Xi Chen, Zhiyu Tang, et al.
Angewandte Chemie (International Ed. in English)
|
March 7, 2026
Oxidative Damage Fine-Tunes G-Quadruplex Structures in Human Gene Promoters
Yu Wang, Yingying Wang, Rongshuang Cheng, et al.
Clinical and Translational Science
|
March 22, 2024
Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors
Tian Yu, Xiangyu Liu, Chi-Yuan Wu, et al.
Page
of 6